PHGDH defines a metabolic subtype in lung adenocarcinomas with poor prognosis
Open accessAbstract
Molecular signatures are emerging determinants of choice of therapy for lung adenocarcinomas. An evolving therapeutic approach includes targeting metabolic dependencies in cancers. Here, using an integrative approach, we have dissected the metabolic fingerprints of lung adenocarcinomas, and we show that Phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme in serine biosynthesis, is highly expressed in a adenocarcinoma subset with poor prognosis. This subset harbors a gene signature for DNA replication and proliferation. Accordingly, models with high levels of PHGDH display rapid proliferation, migration, and selective channeling of serine-derived carbons to glutathione and pyrimidines, while depletion of PHGDH shows potent and selective toxicity to this subset. Differential PHGDH protein levels were defined by its degradation, and the deubiquitinating enzyme JOSD2 is a regulator of its protein stability. Our study provides evidence that a unique metabolic program is activated in a lung adenocarcinoma subset, described by PHGDH, which confers growth and survival and may have therapeutic implications.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increased PHGDH expression leads to greater production of serine from glucose and is associated with specific subsets of breast cancer, lung adenocarcinoma, and melanoma.
“Increased PHGDH gene expression leads to greater production of serine from glucose and is associated with specific subsets of breast cancer, lung adenocarcinoma, and melanoma (Locasale et al., 2011; Possemato et al., 2011; Zhang et al., 2017).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Zhang et al., 2017
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R., Carey, V., Bates, D., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 13,133 · see citing works
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,185 · see citing works
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774 · see citing works
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317 · see citing works
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219 · see citing works
ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization
Yu, G., & He, Q. (2015) · Molecular BioSystems · doi:10.1039/c5mb00663e · Cited by 1,882 · see citing works
A genomic and functional inventory of deubiquitinating enzymes.
Nijman, S. M. B., Luna-Vargas, M. P. A., Velds, A., Brummelkamp, T. R., Dirac, A. M. G., Sixma, T. K., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.11.007 · Cited by 1,854 · see citing works
The DNA damage response and cancer therapy
Lord, C. J., & Ashworth, A. (2012) · Nature · doi:10.1038/nature10760 · Cited by 1,843 · see citing works
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683 · see citing works
Serine, glycine and one-carbon units: cancer metabolism in full circle
Locasale, J. W. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3557 · Cited by 1,669 · see citing works
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,512 · see citing works
Metabolic pathways promoting cancer cell survival and growth
Boroughs, L. K., & DeBerardinis, R. J. (2015) · Nature Cell Biology · doi:10.1038/ncb3124 · Cited by 1,459 · see citing works
Targeting cancer metabolism: a therapeutic window opens
Heiden, M. G. V. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,409 · see citing works
Highly sensitive feature detection for high resolution LC/MS
Tautenhahn, R., Böttcher, C., & Neumann, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-504 · Cited by 1,175 · see citing works
Metabolic heterogeneity in human lung tumors
Hensley, C. T., Faubert, B., Yuan, Q., Lev-Cohain, N., Jin, E., Kim, J., Jiang, L., Ko, B., Skelton, R., Loudat, L., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.034 · Cited by 1,138 · see citing works
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Locasale, J. W., Grassian, A. R., Melman, T., Lyssiotis, C. A., Mattaini, K. R., Bass, A. J., Heffron, G., Metallo, C. M., Muranen, T., Sharfi, H., et al. (2011) · Nature Genetics · doi:10.1038/ng.890 · Cited by 1,120 · see citing works
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
Maddocks, O. D. K., Berkers, C. R., Mason, S. M., Zheng, L., Blyth, K., Gottlieb, E., & Vousden, K. H. (2013) · Nature · doi:10.1038/nature11743 · Cited by 1,007 · see citing works
Serine and one-carbon metabolism in cancer
Yang, M., & Vousden, K. H. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.81 · Cited by 992 · see citing works
Regulation of mammalian nucleotide metabolism and biosynthesis
Lane, A. N., & Fan, T. W.-M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv047 · Cited by 959 · see citing works
Cancer Cell Metabolism: One Hallmark, Many Faces
Cantor, J. R., & Sabatini, D. M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0345 · Cited by 945 · see citing works
Okayama, H., Kohno, T., Ishii, Y., Shimada, Y., Shiraishi, K., Iwakawa, R., Furuta, K., Tsuta, K., Shibata, T., Yamamoto, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1403 · Cited by 881 · see citing works
NRF2 regulates serine biosynthesis in non–small cell lung cancer
DeNicola, G. M., Chen, P.-H., Mullarky, E., Sudderth, J., Hu, Z., Wu, D., Tang, H., Xie, Y., Asara, J. M., Huffman, K. E., et al. (2015) · Nature Genetics · doi:10.1038/ng.3421 · Cited by 747 · see citing works
The role of mitochondria in metabolism and cell death
Vakifahmetoglu-Norberg, H., Ouchida, A. T., & Norberg, E. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.088 · Cited by 729 · see citing works
Self-citationHao, H.-X., Khalimonchuk, O., Schraders, M., Dephoure, N., Bayley, J.-P., Kunst, H., Devilee, P., Cremers, C. W. R. J., Schiffman, J. D., Bentz, B. G., et al. (2009) · Science · doi:10.1126/science.1175689 · Cited by 702 · see citing works
A roadmap for interpreting 13C metabolite labeling patterns from cells
Buescher, J. M., Antoniewicz, M. R., Boros, L. G., Burgess, S. C., Brunengraber, H., Clish, C. B., DeBerardinis, R. J., Féron, O., Frezza, C., Ghesquière, B., et al. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.02.003 · Cited by 623 · see citing works
New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials
Travis, W. D., Brambilla, E. M., & Riely, G. J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.9270 · Cited by 602 · see citing works
Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma
Caro, P., Kishan, A. U., Norberg, E., Stanley, I. A., Chapuy, B., Ficarro, S. B., Polak, K. Z., Tondera, D., Gounarides, J., Yin, H. X., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.014 · Cited by 522 · see citing works
Self-citationPyruvate carboxylase is critical for non–small-cell lung cancer proliferation
Sellers, K., Fox, M. P., Bousamra, M., Slone, S. P., Higashi, R. M., Miller, D. M., Wang, Y., Yan, J., Yuneva, M. O., Deshpande, R., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci72873 · Cited by 497 · see citing works
The importance of serine metabolism in cancer
Mattaini, K. R., Sullivan, M. R., & Heiden, M. G. V. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201604085 · Cited by 409 · see citing works
Botling, J., Edlund, K., Lohr, M., Hellwig, B., Holmberg, L., Lambe, M., Berglund, A., Ekman, S., Bergqvist, M., Pontén, F., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1139 · Cited by 359 · see citing works
Scheltema, R. A., Jankevics, A., Jansen, R. C., Swertz, M. A., & Rainer Breitling, A. (2011) · Analytical Chemistry · doi:10.1021/ac2000994 · Cited by 327 · see citing works
Enzymes of serine metabolism in normal, developing and neoplastic rat tissues
Snell, K. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90021-9 · Cited by 267 · see citing works
Baek, G., Tse, Y. F., Hu, Z., Cox, D., Buboltz, N., McCue, P. A., Yeo, C. J., White, M. A., DeBerardinis, R. J., Knudsen, E. S., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.025 · Cited by 221 · see citing works
Metabolic enzymes as oncogenes or tumor suppressors
Thompson, C. B. (2009) · New England Journal of Medicine · doi:10.1056/nejme0810213 · Cited by 213 · see citing works
Kampf, C., Olsson, I., Ryberg, U., Sjöstedt, E., & Pontén, F. (2012) · Journal of Visualized Experiments · doi:10.3791/3620 · Cited by 197 · see citing works
Kim, H. S., Mendiratta, S., Kim, J., Pecot, C. V., Larsen, J. E., Zubovych, I., Seo, B. Y., Kim, J., Eskiocak, B., Chung, H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.041 · Cited by 172 · see citing works
The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase
Pollard, P., Wortham, N., & Tomlinson, I. (2003) · Annals of Medicine · doi:10.1080/07853890310018458 · Cited by 159 · see citing works
Emerging Understanding of Multiscale Tumor Heterogeneity
Gerdes, M. J., Sood, A., Sevinsky, C. J., Pris, A. D., Zavodszky, M. I., & Ginty, F. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00366 · Cited by 118 · see citing works
The potential of exploiting DNA-repair defects for optimizing lung cancer treatment
Postel-Vinay, S. C., Vanhecke, E., Olaussen, K. A., Lord, C. J., Ashworth, A., & Soria, J. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.3 · Cited by 113 · see citing works
Chokkathukalam, A., Jankevics, A., Creek, D. J., Achcar, F., Barrett, M. P., & Rainer Breitling, A. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts674 · Cited by 101 · see citing works
Metabolic control analysis of mammalian serine metabolism
Snell, K., & Fell, D. A. (1990) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(90)90006-n · Cited by 55 · see citing works
Changing appetites: the adaptive advantages of fuel choice
Stanley, I. A., Ribeiro, S. M., Giménez-Cassina, A., Norberg, E., & Danial, N. N. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.07.010 · Cited by 55 · see citing works
Self-citationNorberg, E., Karlsson, M., Korenovska, O., Szydlowski, S. N., Silberberg, G., Uhlén, P., Orrenius, S., & Zhivotovsky, B. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.253 · Cited by 39 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971 · see citing works
Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition
Ngo, B., Kim, E., Osorio-Vasquez, V., Doll, S., Bustraan, S., Liang, R. J., Luengo, A., Davidson, S. M., Ali, A., Ferraro, G. B., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1228 · Cited by 268 · see citing works
The ins and outs of serine and glycine metabolism in cancer
Geeraerts, S. L., Heylen, E., Keersmaecker, K. D., & Kampen, K. R. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00329-9 · Cited by 250 · see citing works
Serine, glycine and one‑carbon metabolism in cancer (Review)
Pan, S., Fan, M., Liu, Z., Li, X., & Wang, H. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5158 · Cited by 227 · see citing works
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models
Nguyen, T. T. T., Zhang, Y., Shang, E., Shu, C., Torrini, C., Zhao, J., Bianchetti, E., Mela, A., Humala, N., Mahajan, A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129049 · Cited by 201 · see citing works
Shen, L., Zhang, J., Zheng, Z., Yang, F., Liu, S., Wu, Y., Chen, Y., Xu, T., Mao, S., Yan, Y., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.74546 · Cited by 176 · see citing works
Wang, K., Luo, L., Fu, S., Wang, M., Wang, Z., Dong, L., Wu, X., Dai, L., Peng, Y., Shen, G., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36708-5 · Cited by 133 · see citing works
Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer
Jin, N., Bi, A., Lan, X., Xu, J., Wang, X., Liu, Y., Wang, T., Tang, S., Zeng, H., Chen, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10427-2 · Cited by 129 · see citing works
The complexity of the serine glycine one-carbon pathway in cancer
Reina‐Campos, M., Díaz-Meco, M. T., & Moscat, J. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201907022 · Cited by 123 · see citing works
Zhang, W., Bouchard, G., Yu, A., Shafiq, M., Jamali, M., Shrager, J. B., Ayers, K., Bakr, S. H., Gentles, A. J., Diehn, M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2928 · Cited by 121 · see citing works
Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response
Ariav, Y., Ch’ng, J., Christofk, H. R., Ron‐Harel, N., & Erez, A. (2021) · Science Advances · doi:10.1126/sciadv.abg6165 · Cited by 109 · see citing works
Effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism
Eriksson, M., Ambroise, G., Ouchida, A. T., Queiroz, A. L., Smith, D. H., Giménez-Cassina, A., Iwanicki, M., Muller, P. A. J., Norberg, E., & Vakifahmetoglu-Norberg, H. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00328-17 · Cited by 107 · see citing works
Self-citationZhang, Y., Yu, H. T., Zhang, J., Gao, H., Wang, S., Li, S., Wei, P., Liang, J., Yu, G., Wang, X., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146187 · Cited by 104 · see citing works
Pranzini, E., Pardella, E., Muccillo, L., Leo, A., Nesi, I., Santi, A., Parri, M., Zhang, T., Uribe, A. H., Lottini, T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111233 · Cited by 105 · see citing works
Dong, J.-K., Lei, H.-M., Liang, Q., Tang, Y., Zhou, Y., Wang, Y., Zhang, S., Li, W., Tong, Y., Zhuang, G., et al. (2018) · Theranostics · doi:10.7150/thno.23177 · Cited by 103 · see citing works
Liu, J., Zhang, C., Wu, H., Sun, X., Li, Y., HUANG, S. H., Yue, X., Lu, S., Shen, Z., Su, X., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci132876 · Cited by 98 · see citing works
Wilson, J. L., Nägele, T., Linke, M., Demel, F., Fritsch, S. D., Mayr, H. K., Cai, Z., Katholnig, K., Sun, X., Fragner, L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.011 · Cited by 97 · see citing works
Ma, X., Li, B., Liu, J., Fu, Y., & Luo, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1053-y · Cited by 97 · see citing works
Yun, H. J., Li, M., Guo, D. S., Jeon, S. M., Park, S. H., Lim, J. S., Lee, S. B., Liu, R. R., Du, L., Kim, S., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02927-3 · Cited by 95 · see citing works
The Role of D-3-Phosphoglycerate Dehydrogenase in Cancer
Zhao, X., Fu, J., Du, J., & Xu, W. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.41051 · Cited by 90 · see citing works
Hulea, L., Gravel, S., Morita, M., Cargnello, M., Uchenunu, O., Im, Y. K., Lehuédé, C., Ma, E. H., Leibovitch, M., McLaughlan, S., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.001 · Cited by 87 · see citing works
Li, Q., Qiu, J., Yang, H., Sun, G., Hu, Y., Zhu, D., Deng, Z., Wang, X., Tang, J., & Jiang, R. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.008 · Cited by 87 · see citing works
The emerging role of targeting cancer metabolism for cancer therapy
Farhadi, P., Yarani, R., Dokaneheifard, S., & Mansouri, K. (2020) · Tumor Biology · doi:10.1177/1010428320965284 · Cited by 86 · see citing works
PHGDH: a novel therapeutic target in cancer
Lee, C. M., Hwang, Y., Kim, M., Park, Y.-C., Kim, H., & Fang, S. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01268-1 · Cited by 81 · see citing works
Ishida, C. T., Zhang, Y., Bianchetti, E., Shu, C., Nguyen, T. T. T., Kleiner, G., Sanchez‐Quintero, M. J., Quinzii, C. M., Westhoff, M., Karpel‐Massler, G., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1040 · Cited by 80 · see citing works
High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells
Jeong, S., Savino, A. M., Chirayil, R., Barin, E., Cheng, Y., Park, S., Schurer, A., Mullarky, E., Cantley, L. C., Kharas, M. G., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.005 · Cited by 76 · see citing works
Weinstabl, H., Treu, M., Rinnenthal, J., Zahn, S. K., Ettmayer, P., Bader, G., Dahmann, G., Kessler, D., Rumpel, K., Mischerikow, N., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00718 · Cited by 79 · see citing works
Hasan, M. N., Capuk, O., Patel, S. M., & Sun, D. (2022) · Cancers · doi:10.3390/cancers14143331 · Cited by 72 · see citing works
Wang, C., Wan, X., Yu, T., Huang, Z., Shen, C., Qi, Q., Xiang, S., Chen, X., Arbely, E., Ling, Z.-Q., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108021 · Cited by 70 · see citing works
The NAD+ Salvage Pathway Supports PHGDH-Driven Serine Biosynthesis
Murphy, J. P., Giacomantonio, M., Paulo, J. A., Everley, R. A., Kennedy, B. E., Pathak, G. P., Clements, D. R., Kim, Y., Dai, C., Sharif, T., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.086 · Cited by 70 · see citing works
NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis.
Guo, H., Xu, J., Zheng, Q., He, J.-L., Zhou, W., Wang, K., Huang, X., Fan, Q.-J., Ma, J., Cheng, J.-K., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.09.010 · Cited by 70 · see citing works
Wu, X., Xia, J., Zhang, J., Zhu, Y., Wu, Y., Guo, J., Chen, S., Lei, Q., Meng, B., Kuang, C., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16503 · Cited by 65 · see citing works
The PHGDH enigma: Do cancer cells only need serine or also a redox modulator?
Li, A. M., & Ye, J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.036 · Cited by 65 · see citing works
Cycling back to folate metabolism in cancer
Lee, Y., Vousden, K. H., & Hennequart, M. (2024) · Nature Cancer · doi:10.1038/s43018-024-00739-8 · Cited by 65 · see citing works
A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism
Zhao, J.-Y., Feng, K., Wang, F., Zhang, J., Cheng, J. F., Lin, G., Gao, D., & Tian, P. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113379 · Cited by 55 · see citing works
SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness
Nguyen, C. H., Glüxam, T., Schlerka, A., Bauer, K., Grandits, A. M., Hackl, H., Dovey, O. M., Zöchbauer‐Müller, S., Cooper, J. L., Vassiliou, G. S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45579-0 · Cited by 53 · see citing works
Cysteine as a Carbon Source, a Hot Spot in Cancer Cells Survival
Serpa, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00947 · Cited by 53 · see citing works
MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma
Zhang, Y., Nguyen, T. T. T., Shang, E., Mela, A., Humala, N., Mahajan, A., Zhao, J., Shu, C., Torrini, C., Sanchez‐Quintero, M. J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1389 · Cited by 52 · see citing works
Characterization of the Role of the Malate Dehydrogenases to Lung Tumor Cell Survival
Zhang, B., Tornmalm, J., Widengren, J., Vakifahmetoglu-Norberg, H., & Norberg, E. (2017) · Journal of Cancer · doi:10.7150/jca.19373 · Cited by 53 · see citing works
Self-citation3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment
Li, M., Wu, C., Yang, Y., Zheng, M., Yu, S., Wang, J., Chen, L., & Li, H. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00599-9 · Cited by 52 · see citing works
Menin regulates the serine biosynthetic pathway in Ewing sarcoma
Svoboda, L. K., Teh, S. S. K., Sud, S., Kerk, S. A., Zebolsky, A. L., Treichel, S., Thomas, D. G., Halbrook, C. J., Lee, H., Kremer, D. M., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5085 · Cited by 51 · see citing works
Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression
Qian, M., Yan, F., Wang, W., Du, J., Yuan, T., Wu, R., Zhao, C., Wang, J., Lu, J., Zhang, B., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.003 · Cited by 49 · see citing works
Self-citationLinking Serine/Glycine Metabolism to Radiotherapy Resistance
Sánchez-Castillo, A., Vooijs, M., & Kampen, K. (2021) · Cancers · doi:10.3390/cancers13061191 · Cited by 37 · see citing works
PHGDH as a mechanism for resistance in metabolically-driven cancers
Rathore, R., Schutt, C. R., & Tine, B. A. V. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.46 · Cited by 46 · see citing works
Metabolomics of lung cancer: Analytical platforms and their applications
Noreldeen, H. A. A., Liu, X., & Xu, G. (2019) · Journal of Separation Science · doi:10.1002/jssc.201900736 · Cited by 45 · see citing works
The deubiquitinase JOSD2 is a positive regulator of glucose metabolism
Krassikova, L., Zhang, B., Nagarajan, D., Queiroz, A. L., Kacal, M., Samakidis, E., Vakifahmetoglu-Norberg, H., & Norberg, E. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00639-1 · Cited by 45 · see citing works
Self-citationSerine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression
Barnabas, G. D., Lee, J. S., Shami, T., Harel, M., Beck, L., Selitrennik, M., Jerby‐Arnon, L., Erez, N., Ruppin, E., & Geiger, T. (2021) · Cancer Research · doi:10.1158/0008-5472.can-19-3020 · Cited by 44 · see citing works
Zhang, C., Yu, J.-J., Yang, C., Yuan, Z.-L., Zeng, H., Wang, J., Shang, S., Lv, X.-X., Liu, X.-T., Liu, J., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade4113 · Cited by 45 · see citing works
Rawat, V., Malvi, P., Della Manna, D., Yang, E. S., Bugide, S., Zhang, X., Gupta, R., & Wajapeyee, N. (2021) · Oncogene · doi:10.1038/s41388-021-01683-y · Cited by 43 · see citing works
Yu, L., Teoh, S. T., Ensink, E., Ogrodzinski, M. P., Yang, C., Vazquez, A. I., & Lunt, S. Y. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0205-z · Cited by 43 · see citing works
Nyen, T. V., Planque, M., van Wagensveld, L., Duarte, J. A. G., Zaal, E. A., Talebi, A., Rossi, M., Körner, P.-R., Rizzotto, L., Moens, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32272-6 · Cited by 43 · see citing works
Metabolism in tumour-associated macrophages: a<i>quid pro quo</i>with the tumour microenvironment
Zheng, X., Mansouri, S., Krager, A., Grimminger, F., Seeger, W., Pullamsetti, S. S., Wheelock, C. E., & Savai, R. (2020) · European Respiratory Review · doi:10.1183/16000617.0134-2020 · Cited by 41 · see citing works
Chan, F.-F., Kwan, K. K., Seoung, D.-H., Chin, D. W., Ng, I. O., Wong, C. C., & Wong, C. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.10.025 · Cited by 40 · see citing works
Zhang, G., Yang, Y., Hu, H., Liu, K., Li, B., Zhu, Y., Wang, Z., Wu, Q., & Mei, Y. (2021) · Oncogene · doi:10.1038/s41388-021-01749-x · Cited by 39 · see citing works
Jin, L., Kiang, K. M. Y., Cheng, S. Y., & Leung, G. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00666-7 · Cited by 38 · see citing works
Han, J., Fang, Z., Han, B., Ye, B., Lin, W., Jiang, Y., Han, X., Wang, X., Wu, G., Wang, Y., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00313-y · Cited by 38 · see citing works
High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer
Jeon, M. J., You, M., Han, J. M., Sim, S., Yoo, H. J., Lee, W. K., Kim, T. Y., Song, D. E., Shong, Y. K., Kim, W. G., et al. (2020) · Thyroid · doi:10.1089/thy.2020.0105 · Cited by 38 · see citing works
Target enzymes in serine‐glycine‐one‐carbon metabolic pathway for cancer therapy
Sun, W. Y., Zhao, E., & Cui, H. (2022) · International Journal of Cancer · doi:10.1002/ijc.34353 · Cited by 39 · see citing works
Sharif, T., Martell, E., Dai, C., Ghassemi-Rad, M. S., Lee, K., Singh, S. K., Weaver, I. C. G., & Gujar, S. A. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0997-8 · Cited by 36 · see citing works
One carbon metabolism in human lung cancer
Yao, S., Peng, L., Elakad, O., Küffer, S., Hinterthaner, M., Danner, B. C., von Hammerstein-Equord, A. F., Ströbel, P., & Bohnenberger, H. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-1039 · Cited by 36 · see citing works
Serine–glycine-one-carbon metabolism: vulnerabilities in MYCN-amplified neuroblastoma
Zhao, E., Hou, J., & Cui, H. (2020) · Oncogenesis · doi:10.1038/s41389-020-0200-9 · Cited by 32 · see citing works
Phosphoglycerate dehydrogenase (PHGDH) inhibitors: a comprehensive review 2015–2020
Spillier, Q., & Frédérick, R. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1890028 · Cited by 32 · see citing works
Systemic evolutionary chemical space exploration for drug discovery
Lu, C., Liu, S., Shi, W., Yu, J., Zhou, Z., Zhang, X., Lu, X., Cai, F., Xia, N., & Wang, Y. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-022-00598-4 · Cited by 30 · see citing works
Jiang, P., Sun, W., Shen, N., Huang, X., & Fu, S. (2020) · BMC Cancer · doi:10.1186/s12885-020-07345-8 · Cited by 30 · see citing works
Bi, F., An, Y., Sun, T., You, Y., & Yang, Q. F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.643129 · Cited by 30 · see citing works
The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment
Zhou, X., Tian, C., Cao, Y., Zhao, M., & Wang, K. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1084609 · Cited by 30 · see citing works
miR-126-5p targets Malate Dehydrogenase 1 in non-small cell lung carcinomas
Queiroz, A. L., Zhang, B., Comstock, D. E., Hao, Y., Eriksson, M., Hydbring, P., Vakifahmetoglu-Norberg, H., & Norberg, E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.154 · Cited by 29 · see citing works
Self-citationLuo, W., Zou, Z., Nie, Y., Luo, J., Ming, Z., Hu, X., Luo, T., Ouyang, M., Mingquan, L., Tang, H., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06672-z · Cited by 28 · see citing works
ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC
Wang, H., Lin, F., Xu, Z., Yu, S., Li, G., Liao, S., Zhao, W., Zhang, F., Wang, J., Wang, S., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.06.006 · Cited by 28 · see citing works
Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer
Sánchez‐Castillo, A., Heylen, E., Hounjet, J., Savelkouls, K. G. M., Lieuwes, N. G., Biemans, R., Dubois, L. J., Reynders, K., Rouschop, K. M. A., Vaes, R. D. W., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02553-y · Cited by 27 · see citing works
The role of deubiquitinating enzymes in gastric cancer (Review)
Sun, J., Shi, X., Mamun, M., & Gao, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.11062 · Cited by 27 · see citing works
Ambroise, G., Yu, T., Zhang, B., Kacal, M., Hao, Y., Queiroz, A. L., Ouchida, A. T., Lindskog, C., Norberg, E., & Vakifahmetoglu-Norberg, H. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0972-x · Cited by 26 · see citing works
Self-citationKhan, A., Siddiqui, S. I., Husain, S. A., Mazurek, S., & Iqbal, M. A. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c01173 · Cited by 27 · see citing works
Lee, H.-T., Lin, C.-S., Liu, C., Chen, P., Tsai, C., & Wei, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179458 · Cited by 26 · see citing works
Hamano, M., Tomonaga, S., Osaki, Y., Oda, H., Kato, H., & Furuya, S. (2020) · Nutrients · doi:10.3390/nu12103018 · Cited by 25 · see citing works
Yuan, T., Zeng, C., Liu, J., Zhao, C., Ge, F., Li, Y., Qian, M., Du, J., Wang, W., Li, Y., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01706-y · Cited by 24 · see citing works
Insights on Metabolic Reprogramming and Its Therapeutic Potential in Acute Leukemia
Martino, L. D., Tosello, V., Peroni, E., & Piovan, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168738 · Cited by 25 · see citing works
Biyik‐Sit, R., Kruer, T. L., Dougherty, S. M., Bradley, J. A., Wilkey, D. W., Merchant, M. L., Trent, J. O., & Clem, B. F. (2021) · Cancers · doi:10.3390/cancers13163938 · Cited by 23 · see citing works
Discovery of Novel Drug-like PHGDH Inhibitors to Disrupt Serine Biosynthesis for Cancer Therapy
Gao, D., Tang, S., Cen, Y., Yuan, L., Lan, X., Li, Q., Lin, G., Huang, M., & Tian, P. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01202 · Cited by 22 · see citing works
Sun, S., Li, C., Cui, K., Liu, B., Zhou, M., Cao, Y., Zhang, J., Bian, Z., Fei, B., & Huang, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.770006 · Cited by 21 · see citing works
Metabolic Potential of Cancer Cells in Context of the Metastatic Cascade
Benzarti, M., Delbrouck, C., Neises, L., Kiweler, N., & Meiser, J. (2020) · Cells · doi:10.3390/cells9092035 · Cited by 21 · see citing works
JOSD2 regulates PKM2 nuclear translocation and reduces acute myeloid leukemia progression
Lei, H., Yang, L. C., Wang, Y., Zou, Z., Liu, M., Xu, H., & Wu, Y. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00295-w · Cited by 21 · see citing works
Drugging cancer metabolism: Expectations vs. reality
Montrose, D. C., & Galluzzi, L. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.07.007 · Cited by 21 · see citing works
Cai, H., Zhang, F., Xu, F., & Yang, C.-H. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1564226 · Cited by 20 · see citing works
Chung, K., Huang, Y., Chen, Y., Juan, Y., Hsu, C., Nakahira, K., Huang, Y., Lin, M., Wu, S., Shih, J., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12843 · Cited by 18 · see citing works
Zhang, X., Sun, M., Jiao, Y., Lin, B., & Yang, Q. F. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9029544 · Cited by 17 · see citing works
Prognostic significance of phosphoglycerate dehydrogenase in breast cancer
Chandrika, M., Chua, P. J., Muniasamy, U., Huang, R. Y., Thike, A. A., Ng, C. T., Tan, P. H., Yip, G. W., & Bay, B. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06123-9 · Cited by 17 · see citing works
JOSD2 mediates isoprenaline-induced heart failure by deubiquitinating CaMKIIδ in cardiomyocytes
Xu, J., Liang, S., Wang, Q., Zheng, Q., Wang, M., Qian, J., Yu, T., Lou, S., Luo, W., Zhou, H., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05037-7 · Cited by 15 · see citing works
Joint Transcriptomic Analysis of Lung Cancer and Other Lung Diseases
Otálora-Otálora, B. A., Florez, M., López-Kleine, L., Cañas, A., Urrego, D. M. G., & Rojas, A. P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01260 · Cited by 15 · see citing works
Competition between p53 and YY1 determines PHGDH expression and malignancy in bladder cancer
Shi, T., Yuan, Z., He, Y., Zhang, D., Chen, S., Wang, X., Yao, L., Shao, J., & Wang, X. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00823-8 · Cited by 14 · see citing works
Wang, Y., Li, Z., Wang, J., Li, L.-H., Shen, W.-L., & Dang, X. (2022) · Genes & Genomics · doi:10.1007/s13258-022-01356-4 · Cited by 13 · see citing works
The enzymes of serine synthesis pathway in cancer metastasis
Li, L., Qin, Y., & Chen, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119697 · Cited by 13 · see citing works
Zafeiriadou, A., Kollias, I., Londra, T., Tsaroucha, E., Georgoulias, V., Kotsakis, A. P., Lianidou, E. S., & Markou, A. N. (2022) · Cancers · doi:10.3390/cancers14133237 · Cited by 12 · see citing works
Dragic, D., Chang, S.-L., Ennour‐Idrissi, K., Durocher, F., Severi, G., & Diorio, C. (2022) · Epigenomics · doi:10.2217/epi-2022-0055 · Cited by 12 · see citing works
Shu, M., Liu, Y., & Wang, J. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02327-4 · Cited by 12 · see citing works
Jasani, N., Xu, X., Posorske, B., Kim, Y., Wang, K., Vera, O., Tsai, K. Y., DeNicola, G. M., & Karreth, F. A. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-2471 · Cited by 11 · see citing works
Moonlighting functions of phosphoglycerate dehydrogenase in cancer
Wang, C., An, S., Zhao, L., Li, S., Huang, J., & Ren, W. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115940 · Cited by 11 · see citing works
Hamza, M. S., Ramadan, E. S., & Salama, S. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-88346-w · Cited by 11 · see citing works
Glucose metabolism in B cell malignancies: a focus on glycolysis branching pathways
Simon‐Molas, H., Prete, R. D., & Kabanova, A. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13570 · Cited by 10 · see citing works
Serine synthesis and catabolism in starved lung cancer and primary bronchial epithelial cells
Haitzmann, T., Schindlmaier, K., Frech, T., Mondal, A., Bubalo, V., Konrad, B., Bluemel, G., Stiegler, P., Lackner, S., Hrzenjak, A., et al. (2024) · Cancer & Metabolism · doi:10.1186/s40170-024-00337-3 · Cited by 10 · see citing works
- Authors
- Zhang, B., Zheng, A., Hydbring, P., Ambroise, G., Ouchida, A. T., Goiny, M., Vakifahmetoglu-Norberg, H., & Norberg, E.
- Affiliations
- Karolinska Institutet (SE)
- Corresponding author
- Vakifahmetoglu-Norberg, Helin
- Norberg, Erik
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 19
- Issue
- 11
- Pages
- 2289-2303
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W2626649132
- Cited by
- 178
- References
- 44
- Citations by year
- 2026: 14 · 2025: 14 · 2024: 29 · 2023: 14 · 2022: 22 · 2021: 23 · 2020: 31 · 2019: 16 · 2018: 11 · 2017: 4
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cell Reports (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Jeanssons Stiftelser
- O. E. och Edla Johanssons Vetenskapliga Stiftelse
- Svenska Sällskapet för Medicinsk Forskning
- Stiftelsen Längmanska Kulturfonden
- Karolinska Institutet
- Alex och Eva Wallströms Stiftelse för Vetenskaplig Forskning och Utbildning
- Vetenskapsrådet
- Ragnar Söderbergs stiftelse
- Magnus Bergvalls Stiftelse
- Åke Wiberg Stiftelse
- Stiftelsen Lars Hiertas Minne
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- PHGDH, lung adenocarcinoma, serine biosynthesis, cancer metabolism, metabolic subtypes, prognosis, protein stability, deubiquitination, glutathione, pyrimidine synthesis, DNA replication, cell proliferation, tumor cell migration, metabolic dependencies
- MeSH terms
- Adenocarcinoma of Lung, Adenocarcinoma, Animals, DNA, Neoplasm, Female, Humans, Lung Neoplasms, Mice, Nude, Prognosis, Serine, Mice, SCID, Cell Line, Tumor, Cell Proliferation, Phosphoglycerate Dehydrogenase, Mice, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review